The PI3K/mTOR dual inhibitor BEZ235 can inhibit the proliferation and migration of multidrug-resistant AML cell lines (HL-60/VCR and K562/ADR), and improve their sensitivity to VCR and ADR. The gene discussed is PIK3CA; the disease is acute myeloid leukemia.